Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Seitz, Christian [VerfasserIn]   i
 Häcker, Axel [VerfasserIn]   i
Titel:Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy
Verf.angabe:Christian Seitz, Mahesh Desai, Axel Häcker, Oliver W. Hakenberg, Evangelos Liatsikos, Udo Nagele, David Tolley
Jahr:2012
Umfang:13 S.
Fussnoten:Published online ahead of print on September 28, 2011 ; Gesehen am 03.07.2018
Titel Quelle:Enthalten in: European urology
Ort Quelle:Amsterdam [u.a.] : Elsevier Science, 1976
Jahr Quelle:2012
Band/Heft Quelle:61(2012), 1, Seite 146-158
ISSN Quelle:1873-7560
 1421-993X
Abstract:Context: Incidence, prevention, and management of complications of percutaneous nephrolitholapaxy (PNL) still lack consensus. Objective: To review the pidemiology of complications and their prevention and management. Evidence acquisition: A literature review was performed using the PubMed database between 2001 and May 1, 2011, restricted to human species, adults, and the English language. The Medline search used a strategy including medical subject headings (MeSH) and free-text protocols with the keywords percutaneous, nephrolithotomy, PCNL, PNL, urolithiasis, complications, and Clavien, and the MeSH terms nephrostomy, percutaneous/adverse effects, and intraoperative complications or postoperative complications. Evidence synthesis: Assessing the epidemiology of complications is difficult because definitions of complications and their management still lack consensus. For a reproducible quality assessment, data should be obtained in a standardized manner, allowing for comparison. An approach is the validated Dindo-modified Clavien system, which was originally reported by seven studies. No deviation from the normal postoperative course (Clavien 0) was observed in 76.7% of PNL procedures. Including deviations from the normal postoperative course without the need for pharmacologic treatment or interventions (Clavien 1) would add up to 88.1%. Clavien 2 complications including blood transfusion and parenteral nutrition occurred in 7%; Clavien 3 complications requiring intervention in 4.1.%; Clavien 4, life-threatening complications, in 0.6%; and Clavien 5, mortality, in 0.04%. High-quality data on complication management of rare but potentially debilitating complications are scarce and consist mainly of case reports. Conclusions: Complications after PNL can be kept to a minimum in experienced hands with the development of new techniques and improved technology. A modified procedure-specific Clavien classification should be established that would need to be validated in prospective trials.
DOI:doi:10.1016/j.eururo.2011.09.016
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: http://dx.doi.org/10.1016/j.eururo.2011.09.016
 Volltext: http://www.sciencedirect.com/science/article/pii/S0302283811010232
 DOI: https://doi.org/10.1016/j.eururo.2011.09.016
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:Clavien
 Complication
 Incidence
 Management
 PCNL
 Percutaneous nephrolitholapaxy
 PNL
 Prevention
 Review
 Urolithiasis
K10plus-PPN:1577238567
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68280149   QR-Code
zum Seitenanfang